Abstract
Cisplatin-based combination chemotherapy is the standard treatment of advanced urinary tract cancer (aUTC), but 50% of patients are ineligible for cisplatin according to recently published criteria. We used a multinational database to study patterns of chemotherapy utilization in patients with aUTC and determine their impact on survival. This was a retrospective study of patients with: UTC (bladder, renal pelvis, ureter or urethra); advanced disease (stages T4b and/or N+ and/or M+); urothelial, squamous or adenocarcinoma histology. Primary objective was overall survival (OS). Eligibility-for-cisplatin was defined by Eastern Cooperative Oncology Group performance status ≤ 1, creatinine clearance ≥ 60 ml/min, no hearing loss, no neuropathy and no heart failure. Cox regression multivariate analyses were used to establish independent associations of cisplatin versus noncisplatin-based chemotherapy on OS. 1794 patients treated between 2000 and 2013 at 29 centers were analyzed. Median follow-up was 29.1 months. About 1333 patients (74%) received first-line chemotherapy: the use of first-line chemotherapy was associated with longer OS: [hazard ratio (HR): 1.91, 95% confidence interval (CI): 1.67-2.20]. Type of first-line chemotherapy ...Continue Reading
References
Oct 3, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D F BajorinM G Boyle
Jul 15, 2000·Oncology·J CarlesR Ibeas
Sep 23, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H von der MaaseP F Conte
May 16, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C N SternbergUNKNOWN European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group
Oct 26, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J BellmuntJ Baselga
Dec 11, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A BamiasUNKNOWN Hellenic Cooperative Oncology Group
Sep 8, 2004·Urology·Helena LinardouUNKNOWN Phase II study of Hellenic Co-operative Oncology Group
Jun 15, 2006·Cancer·Atreya DashBernard H Bochner
May 15, 2008·Oncology·Aristotle BamiasMeletios A Dimopoulos
Sep 30, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Maria De SantisRichard Sylvester
May 11, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Matthew D GalskyJoaquim Bellmunt
Feb 22, 2012·Clinical Genitourinary Cancer·Guru SonpavdeNicholas J Vogelzang
Mar 1, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joaquim BellmuntRonald de Wit
Nov 9, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A BamiasM A Dimopoulos
Aug 7, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J BellmuntUNKNOWN ESMO Guidelines Working Group
Oct 7, 2015·Clinical Genitourinary Cancer·Aristotle BamiasMeletios A Dimopoulos
Sep 18, 2016·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Jorge D RamosUNKNOWN Retrospective International Study of Cancers of the Urothelium (RISC) Investigators
Oct 12, 2016·European Urology·Andrea NecchiUNKNOWN RISC Investigators
Dec 13, 2016·Lancet·Arjun V BalarUNKNOWN IMvigor210 Study Group
Dec 22, 2016·Cancer Medicine·Jorge D RamosUNKNOWN RISC Investigators
Citations
Jun 27, 2018·PloS One·Sébastien Bontemps-GalloFrank C Gherardini
Feb 12, 2019·Current Treatment Options in Oncology·David J Einstein, Guru Sonpavde
Jan 18, 2018·Nature Reviews. Urology·Jay D Raman
Apr 3, 2019·The Oncologist·Aristotelis BamiasMatthew D Galsky
Aug 28, 2020·Asia-Pacific Journal of Clinical Oncology·Darren Ming-Chun Poon
Jul 9, 2020·Cancer Management and Research·Christine FischerAxel Hegele
Oct 14, 2020·Nature Medicine·Jianjun GaoPadmanee Sharma
Feb 8, 2021·European Urology Focus·Zhenjie WuLinhui Wang
Jan 13, 2021·Nature Reviews. Urology·Di Maria JiangSrikala S Sridhar
Dec 17, 2020·Molecular Cancer Research : MCR·Omar AlhalabiVivek Subbiah
Mar 13, 2021·Targeted Oncology·Enrique GrandeAndrea Necchi
Oct 28, 2019·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Karin HolmstenAnders Ullén
Mar 23, 2021·Oncoimmunology·Lifang GuoZhaohui Tong
May 4, 2021·Radiology and Oncology·Marina MencingerUrska Bokal
May 14, 2021·ESMO Open·A BamiasC N Sternberg
Aug 3, 2021·European Urology Open Science·Lise H OmlandHelle Pappot
Aug 8, 2021·Clinical Genitourinary Cancer·Omar AlhalabiVivek Subbiah
Jul 10, 2021·Urologic Oncology·Alicia K MorgansGuru Sonpavde